false 0001996210 0001996210 2025-12-01 2025-12-01
 


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 1, 2025
 
BLUM HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
 
Delaware
 
000-56626
 
93-3735199
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
11516 Downey Ave.,
Downey, California
 
90241
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: (888) 909-5564
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company  
 
If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 


 
 

 
Item 1.01. Entry into a Material Definitive Agreement.
 
On December 1, 2025, Blum Holdings, Inc. ("Blüm" or the “Company”) executed and delivered an Unsecured Promissory Note in the principal amount of $200,000 (the “December 1st Note”) to an accredited investor, who is a related person under Regulation S-K (the “Lender”). The December 1st Note has a maturity date of September 26, 2027 and bears interest at a rate of 8.0% per annum payable monthly in arrears, commencing on March 31, 2026. The Company may prepay the principal balance in full at any time without penalty. The December 1st Note is convertible at the Lender’s election into a convertible promissory note that shall include an automatic conversion into the shares of capital stock issued by Blüm at a conversion price equal to 85% of a $20,900,000 pre-money valuation of Blüm (equal to a per share price of $0.98 on a fully diluted basis). The Company shall grant to the Lender warrants to purchase up to 228,571 shares of the Company's common stock, at an exercise price of $0.35 per share. The Unsecured Promissory Note dated December 1, 2025 is a formal agreement for the advance payment of $200,000 received on September 26, 2025 as disclosed in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025.
 
On December 2, 2025, the Company executed and delivered an Unsecured Promissory Note in the principal amount of $200,000 (the “December 2nd Note”) to the Lender. The December 2nd Note has a maturity date of October 30, 2027 and bears interest at a rate of 8.0% per annum payable monthly in arrears, commencing on March 31, 2026. The Company may prepay the principal balance in full at any time without penalty. The December 2nd Note is convertible at the Lender’s election into a convertible promissory note that shall include an automatic conversion into the shares of capital stock issued by Blüm at a conversion price equal to 85% of a $20,900,000 pre-money valuation of Blüm (equal to a per share price of $0.98 on a fully diluted basis). The Company shall grant to the Lender warrants to purchase up to 228,571 shares of the Company's common stock, at an exercise price of $0.35 per share. The Unsecured Promissory Note dated December 2, 2025 is a formal agreement for the advance payment of $200,000 received on October 30, 2025 as disclosed in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025.
 
On December 3, 2025, the Company executed and delivered an Unsecured Promissory Note in the principal amount of $500,000 (the “December 3rd Note”) to the Lender. The December 3rd Note has a maturity date of October 31, 2027 and bears interest at a rate of 8.0% per annum payable monthly in arrears, commencing on March 31, 2026. The Company may prepay the principal balance in full at any time without penalty. The December 3rd Note is convertible at the Lender’s election into a convertible promissory note that shall include an automatic conversion into the shares of capital stock issued by Blüm at a conversion price equal to 85% of a $20,900,000 pre-money valuation of Blüm (equal to a per share price of $0.98 on a fully diluted basis). The Company shall grant to the Lender warrants to purchase up to 571,429 shares of the Company's common stock, at an exercise price of $0.35 per share. The Unsecured Promissory Note dated December 3, 2025 is a formal agreement for the advance payment of $500,000 received on October 31, 2025 as disclosed in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025.
 
On December 4, 2025, the Company executed and delivered an Unsecured Promissory Note in the principal amount of $100,000 (the “December 4th Note”) to the Lender. The December 4th Note has a maturity date of November 14, 2027 and bears interest at a rate of 8.0% per annum payable monthly in arrears, commencing on March 31, 2026. The Company may prepay the principal balance in full at any time without penalty. The December 4th Note is convertible at the Lender’s election into a convertible promissory note that shall include an automatic conversion into the shares of capital stock issued by Blüm at a conversion price equal to 85% of a $20,900,000 pre-money valuation of Blüm (equal to a per share price of $0.98 on a fully diluted basis). The Company shall grant to the Lender warrants to purchase up to 114,286 shares of the Company's common stock, at an exercise price of $0.35 per share.
 
On December 5, 2025, the Company executed and delivered an Unsecured Promissory Note in the principal amount of $500,000 (the “December 5th Note”) to the Lender. The December 5th Note has a maturity date of November 25, 2027 and bears interest at a rate of 8.0% per annum payable monthly in arrears, commencing on March 31, 2026. The Company may prepay the principal balance in full at any time without penalty. The December 5th Note is convertible at the Lender’s election into a convertible promissory note that shall include an automatic conversion into the shares of capital stock issued by Blüm at a conversion price equal to 85% of a $20,900,000 pre-money valuation of Blüm (equal to a per share price of $0.98 on a fully diluted basis). The Company shall grant to the Lender warrants to purchase up to 571,429 shares of the Company's common stock, at an exercise price of $0.35 per share.
 
The unsecured promissory notes described above are collectively referred to herein as the "Notes".
 
The foregoing descriptions of the Notes do not purport to be complete and are qualified in its entirety by reference to the full text of the form of Notes, which are filed as Exhibits 10.1 through 10.5 to this Current Report on Form 8-K and incorporated by reference herein.
 
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
 
The information under Item 1.01, above, is incorporated herein by reference.
 
Item 3.02. Unregistered Sales of Equity Securities.
 
On December 1, 2025, in connection with the December 1st Note, the Company issued warrants to purchase up to 228,571 shares of Common Stock with an exercise price of $0.35 per share to the Lender. The warrants may be exercised at the election of the Lender on a cashless basis in the event that the underlying common shares are unregistered. The warrants are exercisable until December 8, 2028 upon which the warrants shall be automatically exercised on a cashless basis.
 
On December 2, 2025, in connection with the December 2nd Note, the Company issued warrants to purchase up to 228,571 shares of Common Stock with an exercise price of $0.35 per share to the Lender. The warrants may be exercised at the election of the Lender on a cashless basis in the event that the underlying common shares are unregistered. The warrants are exercisable until December 2, 2028 upon which the warrants shall be automatically exercised on a cashless basis.
 
On December 3, 2025, in connection with the December 3rd Note, the Company issued warrants to purchase up to 571,429 shares of Common Stock with an exercise price of $0.35 per share to the Lender. The warrants may be exercised at the election of the Lender on a cashless basis in the event that the underlying common shares are unregistered. The warrants are exercisable until December 3, 2028 upon which the warrants shall be automatically exercised on a cashless basis.
 
On December 4, 2025, in connection with the December 4th Note, the Company issued warrants to purchase up to 114,286 shares of Common Stock with an exercise price of $0.35 per share to the Lender. The warrants may be exercised at the election of the Lender on a cashless basis in the event that the underlying common shares are unregistered. The warrants are exercisable until December 4, 2028 upon which the warrants shall be automatically exercised on a cashless basis.
 
On December 5, 2025, in connection with the December 5th Note, the Company issued warrants to purchase up to 571,429 shares of Common Stock with an exercise price of $0.35 per share to the Lender. The warrants may be exercised at the election of the Lender on a cashless basis in the event that the underlying common shares are unregistered. The warrants are exercisable until December 5, 2028 upon which the warrants shall be automatically exercised on a cashless basis.
 
The common stock purchase warrants described above are collectively referred to herein as the "Warrants".
 
The foregoing descriptions of the Warrants do not purport to be complete and are qualified in its entirety by reference to the full text of the form of Warrants, which are filed as Exhibits 10.6 through 10.10 to this Current Report on Form 8-K and incorporated by reference herein.
 
Item 9.01. Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit
 
Description
10.1   Form of Unsecured Promissory Note, dated December 1, 2025.
10.2   Form of Unsecured Promissory Note, dated December 2, 2025.
10.3   Form of Unsecured Promissory Note, dated December 3, 2025.
10.4   Form of Unsecured Promissory Note, dated December 4, 2025.
10.5   Form of Unsecured Promissory Note, dated December 5, 2025.
10.6   Form of Common Stock Purchase Warrant, dated December 1, 2025.
10.7   Form of Common Stock Purchase Warrant, dated December 2, 2025.
10.8   Form of Common Stock Purchase Warrant, dated December 3, 2025.
10.9   Form of Common Stock Purchase Warrant, dated December 4, 2025.
10.10   Form of Common Stock Purchase Warrant, dated December 5, 2025.
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL Document).
 
 
2

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
BLUM HOLDINGS, INC.
 
     
Date: December 5, 2025
By:
/s/ Sabas Carrillo
 
   
Sabas Carrillo
 
   
Chief Executive Officer
 
 
 
3